Patents by Inventor Sebastien Louis Degorce

Sebastien Louis Degorce has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY
    Publication number: 20240150321
    Abstract: The invention provides pyrazolylsulfonamide compounds, pharmaceutical compositions, their use for inhibiting mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), and their use in the treatment of a disease or condition, such as a proliferative disorder, inflammatory disorder, or autoimmune disorder.
    Type: Application
    Filed: August 25, 2023
    Publication date: May 9, 2024
    Inventors: Yingzhi Bi, Kenneth G. Carson, Geraldine Cirillo Harriman, Sundarapandian Thangapandian, Christian Josef Kuper, Sebastien Louis Degorce, Benjamin Paul Whittaker, Arwel Lewis, Maria Angel Palomero-Vazquez
  • PYRIDINYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY
    Publication number: 20240150365
    Abstract: The invention provides pyridinylsulfonamide compounds, pharmaceutical compositions, their use for inhibiting mucosa-associated lymphoid tissue lymphoma translocation protein 1 (MALT1), and their use in the treatment of a disease or condition, such as a proliferative disorder, inflammatory disorder, or autoimmune disorder.
    Type: Application
    Filed: August 25, 2023
    Publication date: May 9, 2024
    Inventors: Yingzhi BI, Kenneth G. CARSON, Geraldine Cirillo HARRIMAN, Sundarapandian THANGAPANDIAN, Christian Josef KUPER, Sebastien Louis DEGORCE, Arwel LEWIS, Maria Angel PALOMERO-VAZQUEZ, Robert Stuart Laurie CHAPMAN
  • CHEMICAL COMPOUNDS
    Publication number: 20240010631
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Application
    Filed: September 14, 2023
    Publication date: January 11, 2024
    Inventors: JEFFREY WALLACE JOHANNES, SUDHIR MAHADEO HANDE, AVIPSA GHOSH, XIAOLAN ZHENG, MARTIN PACKER, SEBASTIEN LOUIS DEGORCE
  • Chemical compounds
    Patent number: 11795158
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Grant
    Filed: June 22, 2021
    Date of Patent: October 24, 2023
    Assignee: ASTRAZENECA AB
    Inventors: Jeffrey Wallace Johannes, Sudhir Mahadeo Hande, Avipsa Ghosh, Xiaolan Zheng, Martin Packer, Sebastien Louis Degorce
  • CHEMICAL COMPOUNDS
    Publication number: 20220227768
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Application
    Filed: April 7, 2022
    Publication date: July 21, 2022
    Inventors: Jeffrey Wallace Johannes, Sudhir Mahadeo Hande, Sebastien Louis Degorce, Martin John Packer
  • Chemical compounds
    Patent number: 11325906
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: May 10, 2022
    Assignee: ASTRAZENECA AB
    Inventors: Jeffrey Wallace Johannes, Sudhir Mahadeo Hande, Sebastien Louis Degorce, Martin John Packer
  • CHEMICAL COMPOUNDS
    Publication number: 20220009901
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Application
    Filed: June 22, 2021
    Publication date: January 13, 2022
    Inventors: JEFFREY WALLACE JOHANNES, SUDHIR MAHADEO HANDE, AVIPSA GHOSH, XIAOLAN ZHENG, MARTIN PACKER, SEBASTIEN LOUIS DEGORCE
  • CHEMICAL COMPOUNDS
    Publication number: 20210040084
    Abstract: The present invention relates to azaquinolone compounds of Formula (I), and their use in medicine.
    Type: Application
    Filed: July 17, 2020
    Publication date: February 11, 2021
    Inventors: Jeffrey Wallace JOHANNES, Sudhir Mahadeo HANDE, Sebastien Louis DEGORCE, Martin John PACKER
  • Chromenone derivatives
    Patent number: 9718800
    Abstract: The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: March 24, 2016
    Date of Patent: August 1, 2017
    Assignee: ASTRAZENECA AB
    Inventors: Bernard Christophe Barlaam, Sebastien Louis Degorce, Christine Marie Paul Lambert-Van Der Brempt, Remy Robert Morgentin, Patrick Ple
  • CHROMENONE DERIVATIVES
    Publication number: 20160272607
    Abstract: The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: March 24, 2016
    Publication date: September 22, 2016
    Applicant: AstraZeneca AB
    Inventors: Bernard Christophe BARLAAM, Sebastien Louis DEGORCE, Christine Marie, Paul LAMBERT-VAN DER BREMPT, Remy Robert MORGENTIN, Patrick PLE
  • CHROMENONE DERIVATIVES
    Publication number: 20160060240
    Abstract: The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: April 8, 2015
    Publication date: March 3, 2016
    Applicant: ASTRAZENECA AB
    Inventors: Bernard Christophe BARLAAM, Sebastien Louis DEGORCE, Christine Marie, Paul LAMBERT-VAN DER BREMPT, Remy Robert MORGENTIN, Patrick PLE
  • Chromenone derivatives
    Patent number: 9029374
    Abstract: The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: January 24, 2014
    Date of Patent: May 12, 2015
    Assignee: AstraZeneca AB
    Inventors: Bernard Christophe Barlaam, Sebastien Louis Degorce, Christine Marie Paul Lambert-Van Der Brempt, Remy Robert Morgentin, Patrick Ple
  • CHROMENONE DERIVATIVES
    Publication number: 20140194419
    Abstract: The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: January 24, 2014
    Publication date: July 10, 2014
    Applicant: AstraZeneca AB
    Inventors: Bernard Christophe BARLAAM, Sebastien Louis DEGORCE, Christine Marie, Paul LAMBERT-VAN DER BREMPT, Remy Robert MORGENTIN, Patrick PLE
  • Chromenone Derivatives
    Publication number: 20140038937
    Abstract: The invention concerns chromenone compounds of Formula I; or pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, n and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: August 6, 2013
    Publication date: February 6, 2014
    Applicant: Astrazeneca AB
    Inventors: Bernard Christophe BARLAAM, Sebastien Louis DEGORCE, Christine Marie Paul LAMBERT-VAN DER BREMPT, Jean-Jacques Marcel LOHMANN, Patrick PLE
  • Chromenone derivatives
    Patent number: 8530470
    Abstract: The invention concerns chromenone compounds of Formula I; or pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, n and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: April 11, 2012
    Date of Patent: September 10, 2013
    Assignee: Astrazeneca AB
    Inventors: Bernard Christophe Barlaam, Sebastien Louis Degorce, Christine Marie Paul Lambert-Van Der Brempt, Jean-Jacques Marcel Lohmann, Patrick Ple
  • Chromenone derivatives
    Patent number: 8399460
    Abstract: The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Grant
    Filed: October 22, 2010
    Date of Patent: March 19, 2013
    Assignee: Astrazeneca AB
    Inventors: Bernard Chistrophe Barlaam, Sebastien Louis Degorce, Christine Marie Paul Lambert-Van Der Brempt, Remy Robert Morgentin, Patrick Ple
  • CHROMENONE DERIVATIVES
    Publication number: 20120264731
    Abstract: The invention concerns chromenone compounds of Formula I; or pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, n and R6 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: April 11, 2012
    Publication date: October 18, 2012
    Applicant: ASTRAZENECA AB
    Inventors: Bernard Christophe BARLAAM, Sebastien Louis DEGORCE, Christine Marie Paul LAMBERT-VAN DER BREMPT, Jean-Jacques Marcel LOHMANN, Patrick PLE
  • CHROMENONE DERIVATIVES
    Publication number: 20110098271
    Abstract: The invention concerns chromenone derivatives of Formula I or a pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, R6, R7, R8, n and R9 has any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use in the treatment of cell proliferative disorders.
    Type: Application
    Filed: October 22, 2010
    Publication date: April 28, 2011
    Applicant: ASTRAZENECA AB
    Inventors: Bernard Christophe BARLAAM, Sebastien Louis DEGORCE, Christine Marie Paul LAMBERT-VAN DER BREMPT, Remy Robert MORGENTIN, Patrick PLE